Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial
COMPASS Investigators
Research output: Articles / Notes › Scientific Article › peer-review
124Scopus
citations
Fingerprint
Dive into the research topics of 'Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial'. Together they form a unique fingerprint.